The only company not making a profit during the epidemic
At a press conference, WHO Director-General Tedros Adhanom Ghebreyesus reminded that the WHO Global Vaccine Safety Advisory Committee concluded that, according to available data, the AstraZeneca vaccine does not cause clotting. Noting that AstraZeneca announced the positive results of the vaccine trial in more than 32 thousand people in Chile, Peru and the USA, Ghebreyesus said, “The vaccine was 79 percent effective in preventing symptomatic Covid-19 and 100 percent effective in preventing hospitalization and death. is another proof that the vaccine is safe and effective. “
“THE FLIGHT BETWEEN RICH AND POOR COUNTRIES IS GROWING”
Reminding that the world is on the brink of moral failure unless urgent steps are taken to ensure the fair distribution of Covid-19 vaccines, Ghebreyesus said, “We have the tools to prevent this failure, but it is surprising how little can be done to prevent it. Countries that are now vaccinating younger, healthy people with a low risk of Covid-19 disease are doing this at the expense of the lives of healthcare workers, the elderly and other at-risk groups in other countries. ”The unfair distribution of Covid-19 vaccines is not just a moral disgrace. Stating that it also prevents itself economically and epidemiologically, Ghebreyesus said, “While some countries compete to vaccinate all their populations, other countries have nothing”. Noting that the more widespread of the virus will cause more mutations, Ghebreyesus said, “The more variations that occur, the more likely the variations will survive Covid-19 vaccines. As long as the virus continues to spread anywhere, people will continue to die, trade and travel will continue to be interrupted. “and the economic recovery will be delayed further,” he said.
“THE ONLY COMPANY WITHOUT PROFIT DURING THE OUTBREAK”
Stating that AstraZeneca is the only company that did not profit from vaccines produced during the Covid-19 outbreak, Ghebreyesus reported that he spoke with AstraZeneca CEO Pascal Soriot about the company’s difficulties in accelerating vaccine production and spreading vaccines. “So far AstraZeneca is the only company committed to not profit from the Covid-19 vaccine during the pandemic. So far it is the only vaccine developer to make a significant contribution to vaccine capital by licensing its technology to several companies, including SK Bio in South Korea and the Indian Serum Institute,” said Ghebreyesus. ” said.
SAMPLE COUNTRY SOUTH KOREA
Noting that there are some exemplary countries in the world, Ghebreyesus said, “Although South Korea is a high-income country that can easily purchase Covid-19 vaccines through bilateral agreements, it waited for the vaccine queue with COVAX.”